144 related articles for article (PubMed ID: 31860966)
1. Prescription of Chinese herbal products is associated with a decreased risk of uterine fibroids: A population-based cohort study.
Hsu WC; Tsai YT; Hou YC; Lai JN
Medicine (Baltimore); 2019 Dec; 98(51):e18195. PubMed ID: 31860966
[TBL] [Abstract][Full Text] [Related]
2. Prescription of Chinese herbal products is associated with a decreased risk of invasive breast cancer.
Tsai YT; Lai JN; Lo PC; Chen CN; Lin JG
Medicine (Baltimore); 2017 Sep; 96(35):e7918. PubMed ID: 28858112
[TBL] [Abstract][Full Text] [Related]
3. The use of Chinese herbal products and its influence on tamoxifen induced endometrial cancer risk among female breast cancer patients: a population-based study.
Tsai YT; Lai JN; Wu CT
J Ethnopharmacol; 2014 Sep; 155(2):1256-62. PubMed ID: 25048609
[TBL] [Abstract][Full Text] [Related]
4. Prescription pattern of Chinese herbal products for heart failure in Taiwan: A population-based study.
Tsai MY; Hu WL; Lin CC; Lee YC; Chen SY; Hung YC; Chen YH
Int J Cardiol; 2017 Feb; 228():90-96. PubMed ID: 27863367
[TBL] [Abstract][Full Text] [Related]
5. The Use of Chinese Herbal Medicine in the Treatment of Chronic Obstructive Pulmonary Disease (COPD).
Liao YN; Hu WL; Chen HJ; Hung YC
Am J Chin Med; 2017; 45(2):225-238. PubMed ID: 28231744
[TBL] [Abstract][Full Text] [Related]
6. The prescribing of Chinese herbal products in Taiwan: a cross-sectional analysis of the national health insurance reimbursement database.
Hsieh SC; Lai JN; Lee CF; Hu FC; Tseng WL; Wang JD
Pharmacoepidemiol Drug Saf; 2008 Jun; 17(6):609-19. PubMed ID: 18481335
[TBL] [Abstract][Full Text] [Related]
7. Effect of early use of Chinese herbal products on mortality rate in patients with lung cancer.
Shen HS; Wen SH
J Ethnopharmacol; 2018 Jan; 211():1-8. PubMed ID: 28942131
[TBL] [Abstract][Full Text] [Related]
8. The risk of coronary artery disease in patients with rheumatoid arthritis using Chinese herbal products and conventional medicine in parallel: a population-based cohort study.
Yu HH; Hsiung NH; Chiang JH; Shen HS
BMC Complement Med Ther; 2020 Mar; 20(1):100. PubMed ID: 32228568
[TBL] [Abstract][Full Text] [Related]
9. Use of Chinese medicine correlates negatively with the consumption of conventional medicine and medical cost in patients with uterine fibroids: a population-based retrospective cohort study in Taiwan.
Su SY; Muo CH; Morisky DE
BMC Complement Altern Med; 2015 Apr; 15():129. PubMed ID: 25902837
[TBL] [Abstract][Full Text] [Related]
10. Chinese Herbal Products for Female Infertility in Taiwan: A Population-Based Cohort Study.
Hung YC; Kao CW; Lin CC; Liao YN; Wu BY; Hung IL; Hu WL
Medicine (Baltimore); 2016 Mar; 95(11):e3075. PubMed ID: 26986137
[TBL] [Abstract][Full Text] [Related]
11. Prescription patterns of Chinese herbal products for patients with uterine fibroid in Taiwan: A nationwide population-based study.
Yen HR; Chen YY; Huang TP; Chang TT; Tsao JY; Chen BC; Sun MF
J Ethnopharmacol; 2015 Aug; 171():223-30. PubMed ID: 26051833
[TBL] [Abstract][Full Text] [Related]
12. Prescription patterns of Chinese herbal products for patients with sleep disorder and major depressive disorder in Taiwan.
Chen YL; Lee CY; Huang KH; Kuan YH; Chen M
J Ethnopharmacol; 2015 Aug; 171():307-16. PubMed ID: 26068429
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant Chinese Herbal Products for Preventing Ischemic Stroke in Patients with Atrial Fibrillation.
Hung YC; Cheng YC; Muo CH; Chiu HE; Liu CT; Hu WL
PLoS One; 2016; 11(7):e0159333. PubMed ID: 27428543
[TBL] [Abstract][Full Text] [Related]
14. Statin use and uterine fibroid risk in hyperlipidemia patients: a nested case-control study.
Borahay MA; Fang X; Baillargeon JG; Kilic GS; Boehning DF; Kuo YF
Am J Obstet Gynecol; 2016 Dec; 215(6):750.e1-750.e8. PubMed ID: 27371355
[TBL] [Abstract][Full Text] [Related]
15. Chinese Herbal Products for Ischemic Stroke.
Hung IL; Hung YC; Wang LY; Hsu SF; Chen HJ; Tseng YJ; Kuo CE; Hu WL; Li TC
Am J Chin Med; 2015; 43(7):1365-79. PubMed ID: 26477801
[TBL] [Abstract][Full Text] [Related]
16. Concurrent Use in Taiwan of Chinese Herbal Medicine Therapies among Hormone Users Aged 55 Years to 79 Years and Its Association with Breast Cancer Risk: A Population-Based Study.
Tsai YT; Lai JN; Wu CT; Lin SK
Evid Based Complement Alternat Med; 2014; 2014():683570. PubMed ID: 24987432
[TBL] [Abstract][Full Text] [Related]
17. Prescription patterns of Chinese herbal products for patients with fractures in Taiwan: A nationwide population-based study.
Liao HH; Yeh CC; Lin CC; Chen BC; Yeh MH; Chang KM; Sun MF; Yen HR
J Ethnopharmacol; 2015 Sep; 173():11-9. PubMed ID: 26187277
[TBL] [Abstract][Full Text] [Related]
18. Demographic and Prescribing Patterns of Chinese Herbal Products for Individualized Therapy for Ischemic Heart Disease in Taiwan: Population-Based Study.
Hung YC; Tseng YJ; Hu WL; Chen HJ; Li TC; Tsai PY; Chen HP; Huang MH; Su FY
PLoS One; 2015; 10(8):e0137058. PubMed ID: 26322893
[TBL] [Abstract][Full Text] [Related]
19. Soy-Based Infant Formula Feeding and Uterine Fibroid Development in a Prospective Ultrasound Study of Black/African-American Women.
Langton CR; Harmon QE; Upson K; Baird DD
Environ Health Perspect; 2023 Jan; 131(1):17006. PubMed ID: 36696103
[TBL] [Abstract][Full Text] [Related]
20. Frequency and co-prescription pattern of Chinese herbal products for hypertension in Taiwan: a Cohort study.
Yang PR; Shih WT; Chu YH; Chen PC; Wu CY
BMC Complement Altern Med; 2015 Jun; 15():163. PubMed ID: 26048045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
